Consumer health company Kenvue said on Wednesday it had appointed three new directors to its board as part of an agreement ...

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer ...

Starboard Value LP underperformed peers in 2024, a year in which Jeff Smith’s activist firm was frustrated with large ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

The all-or-nothing strategy has landed the ‘pride of the pharmaceutical industry' in a situation that deteriorated rapidly.

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...

Company and Starboard Value LP Enter into Cooperation Agreement SKILLMAN, N.J.--BUSINESS WIRE--Kenvue Inc. (NYSE: KVUE), the world's largest ...

That Pfizer’s turnaround is already well underway is reflected by the fact that activist investor Starboard Value, led by Jeffrey Smith, wisely chose not to nominate any dissident directors to ...

Pfizer got a reprieve in late January when Starboard did not nominate its own slate of directors to the company’s board, but the activist could still agitate for changes in 2026. Among Pfizer ...

Pfizer appears to have dodged a proxy battle with activist investor Starboard Value, which has a roughly $1 billion stake in the pharmaceutical giant, for now. The deadline passed for nominating ...